Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $369496.00.
ENTERPRISE VALUE (EV)
$369496.00
Niki BioSolutions, Inc.
Market Cap
$403887.00
Enterprise Value (EV)
$369496.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Niki BioSolutions, Inc. (NIKI) | $403887.00 | $369496.00 |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | $6.37M |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A |
| CDT Equity Inc. (CDT)vs › | $716854.00 | $971.29M |
Market Cap
$403887.00
Total Debt
$3.42M
Cash
$3.45M
Enterprise Value
$369496.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
